-- 
Colorectal Cancer Drugs by Roche, Amgen Fail to Win U.K. Backing

-- B y   K r i s t e n   H a l l a m
-- 
2011-09-04T23:01:00Z

-- http://www.bloomberg.com/news/2011-09-04/colorectal-cancer-drugs-by-roche-amgen-fail-to-win-u-k-backing.html
Roche Holding AG (ROG) ’s Avastin,  Merck
KGaA (MRK) ’s Erbitux and  Amgen Inc. (AMGN) ’s Vectibix failed to win the
backing of the U.K.’s National Institute for Health and Clinical
Excellence in draft guidelines for treating colorectal cancer
that has spread, according to an e-mailed statement from the
institute.  To contact the reporter on this story:
Kristen Hallam in London at 
 khallam@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  